News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Biogen to Acquire Apellis for $5.6B
Apellis’ C3 complement therapies, Syfovre® and Empaveli® will expand Biogen's presence in immunology.
Penn and CHOP Scientists Win 2026 Breakthrough Prize for Developing Gene Therapy for Inherited Blindness
These faculty developed the first FDA-approved gene therapy for an inherited condition.
Meet the 2026/2027 PCI Fellows Cohort
PCI welcomes the 2026 PCI Fellows consisting of 12 outstanding trainees across Penn’s schools: Penn Engineering (6), Penn Medicine (5), and Penn Arts & Sciences (1).
Investment Funds available for Penn Startups
Penn has three investment funds available for early stage startups affiliated with the University.
Executive Director of Bayh-Dole Coalition Explains the Current State of Bayh Dole
Joe Allen, Executive Director of the Bayh-Dole Coalition, shared insights about recent challenges to the Bayh-Dole Act,
John Swartley Appointed to Ben Franklin Technology Partners of Southeastern Pennsylvania Board of Directors
John Swartley, MBA, PhD, Chief Innovation Officer at Penn, will provide strategic oversight and guidance to support the organization’s mission.
Governor Shapiro Secures Over $1 Billion Investment from Johnson & Johnson to Build Manufacturing Facility in Montgomery County
The facility will directly support the production of medicines for cancer, immune-mediated diseases and neurological diseases.
Governor Shapiro Secures Historic $3.5 Billion Investment from Eli Lilly to Build Pharmaceutical Manufacturing Facility in Lehigh County
Lilly’s investment is the largest by a life sciences company in Pennsylvania's history.
Four Penn Medicine Studies Named Among Nation’s Top 10 Clinical Research Advances
The Clinical Research Forum’s Top 10 Clinical Research Achievement Awards honor outstanding accomplishments in clinical research.
CarboWells Wins the 2026 Y-Prize Competition
The winning idea is based on technology developed by Shu Yang, PhD.